Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot2: STU1 Ballot 2) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions

: Remdesivir IV 200 mg once then 100 mg once daily for 9 days - XML Representation

Raw xml | Download


<Group xmlns="http://hl7.org/fhir">
  <id value="179783"/>
  <meta>
    <versionId value="5"/>
    <lastUpdated value="2025-03-15T21:11:47.281Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-exposure-definition"/>
  </meta>
  <text>
    <status value="empty"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p>[No data.]</p></div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
    <valueContactDetail>
      <name value="Brian S. Alper"/>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as">
    <valueMarkdown
                   value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179783. Revised 2024-12-27. Available at: https://fevir.net/resources/Group/179783. Computable resource at: https://fevir.net/resources/Group/179783#json."/>
  </extension>
  <url value="https://fevir.net/resources/Group/179783"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="urn:ietf:rfc:3986"/>
    <value value="https://fevir.net/FOI/179783"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <name value="Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days"/>
  <title value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days"/>
  <status value="active"/>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description
               value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days"/>
  <copyright value="https://creativecommons.org/licenses/by-nc-sa/4.0/"/>
  <membership value="conceptual"/>
  <characteristic>
    <code>
      <text value="Defined by Reference"/>
    </code>
    <valueReference>🔗 
      <reference value="ActivityDefinition/213"/>
      <type value="ActivityDefinition"/>
      <display value="IV remdesivir 200 mg then 100 mg/day for 9 days"/>
    </valueReference>
    <exclude value="false"/>
    <description
                 value="Remdesivir IV 200 mg once then 100 mg once daily for 9 days"/>
  </characteristic>
</Group>